A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...
Actinogen Medical Limited ( ($AU:ACW) ) has provided an announcement. Actinogen Medical has announced the WHO’s granting of the nonproprietary ...
Biotech company Actinogen Medical is developing Xanamem, a drug designed to inhibit the increased production of cortisol in the brain, which has been linked to cognitive decline and Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results